While Virginia became the first southern state to legalize both medical and recreational use marijuana earlier this year, North Carolina’s bill only focuses on medical marijuana and it is narrowly tailored. SB 711 recognizes that “modern medical research has found that cannabis and cannabinoid compounds are effective at alleviating pain, nausea, and other symptoms associated with several debilitating medical conditions.”
SB 711 would make medical marijuana available to “qualified patients” with a physician’s written certification. To be a qualified patient, an individual must be diagnosed with one of the bill’s select “debilitating” medical conditions (cancer, epilepsy, AIDS, ALS, Parkinson’s disease, multiple sclerosis, and post-traumatic stress disorder, among others, are included in this list). A 13-member Medical Cannabis Advisory Board would be established with the power to add additional conditions to those currently listed.
The Bill also establishes a 9-member Medical Cannabis Production Commission (the “Commission”) with the power to establish the medical cannabis supply system with distribution to occur through medical cannabis centers. The Commission will be tasked to “establish a system that is well regulated, includes a seed-to-sale tracking system, and is financially viable for suppliers to ensure the highest quality cannabis and cannabis-infused products for patients.” Under the Bill, the North Carolina Department of Health and Human Services will evaluate supplier license applications and submit a list of 20 applications to the Commission for approval. As you may imagine, the licensing documentation, processes, and requirements during and after licensing are quite detailed. The current language allows the Commission to issue “no more than 10 supplier licenses.” Additionally, each supplier may “own and operate no more than four medical cannabis centers” thereby limiting the total number of medical cannabis distribution centers to 40 across the entire state.
The Bill’s current language also includes the following provisions:
- The NC Department of Health and Human Services would “establish standards for and license up to five independent testing laboratories to test cannabis and cannabis-infused products that are to be sold in the State.”
- The University of North Carolina is to create a “North Carolina Cannabis Research Program” to provide “objective, scientific research regarding the administration of cannabis or cannabis-infused products as part of medical treatment.”
- Penalties for violations, including enhanced sentencing, would apply if a criminal offense were committed at a medical cannabis center or production facility or with cannabis from a medical cannabis center or production facility.
- Specific advertising, labeling, and packaging requirements, including child-resistant packaging.